ANTIMICROBIAL RESISTANCE (AMR).
Another reason for plant-based medicines is antimicrobial resistance (AMR).
Plant-based medicines offer a compelling alternative to synthetic drugs or laboratory-based medicines, boasting a rich history of human use and proven efficacy. While synthetic medicines may streamline mass production, they often carry greater risks and unforeseen side effects that can take years, even decades, to fully comprehend. In contrast, natural plant-based remedies leverage centuries of documented human use, providing a robust foundation of safety and effectiveness.
The World Health Organization recognizes the inherent value of plant-based medicines, often allowing them to bypass certain early phases of clinical trials due to their established track record. This accelerated pathway not only saves time but also reduces costs, making plant-based medicines an attractive option for both developers and patients alike.
A critical factor driving the urgency for plant-based medicines is the growing threat of antimicrobial resistance (AMR). This phenomenon occurs when microbes evolve to withstand the effects of antimicrobial drugs, rendering once-effective treatments obsolete. AMR poses a significant global health crisis, increasing the risk of disease spread, severe illness, and mortality.
Antimicrobial resistance affects all classes of microbes:
-
Fungi develop antifungal resistance
-
Viruses evolve antiviral resistance
-
Protozoa acquire antiprotozoal resistance
-
Bacteria adapt to become antibiotic-resistant
The emergence of multidrug-resistant (MDR) microbes, often referred to as "superbugs," presents an even more formidable challenge. While AMR is a natural process, it is frequently exacerbated by the improper use of antimicrobial drugs and inadequate infection management practices.
In light of these challenges, plant-based medicines offer a promising solution. By harnessing the power of nature's pharmacy, we can develop innovative treatments that not only combat disease but also potentially circumvent the growing threat of antimicrobial resistance. Embracing this approach could revolutionize modern medicine, providing safer, more effective therapies for patients worldwide.
